Exelixis Inc. buy Royal Bank of Canada
Start price
13.12.23
/
50%
€21.38
Target price
13.12.24
€24.09
Performance (%)
57.81%
End price
14.12.24
€33.74
Summary
This prediction ended on 14.12.24 with a price of €33.74. With a performance of 57.81% the BUY prediction by Royal_Bank_of_Canada was a big success. Royal_Bank_of_Canada has a follow-up prediction for Exelixis Inc. where he still thinks Exelixis Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -0.431% | -0.431% | 10.881% |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $26.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten